Skip to main content

Advertisement

Table 1 Baseline characteristics of included patients in the studies in Boende and Kabalo

From: Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies

Characteristics N Boende Kabalo
SP
107
AQ
106
AS+SP
91
AS+AQ
90
SP
60
AS+SP
62
AS+AQ
58
Males, n (%) 56 (52.3) 54 (50.9) 45 (49.5) 46 (51.1) 26 (43.3) 37 (59.7) 36 (62.1)
Age months
median [range]
18
[6–59]
19
[6–59]
20
[6–56]
21
[6–56]
36
[8–96]
25
[7–108]
33.5
[7–108]
Weight kg
median [range]
9.2
[5.1–18]
10.3
[5.8–22]
9.7
[5.9–17]
9.9
[6.1–16.5]
11
[6–25]
11
[6.7–22]
11
[5.7–26]
MUAC mm
median [range]
140
[112–172]
142
[110–176]
142
[118–170]
138
[124–170]
146
[116–194]
148
[122–180]
149
[116–180]
Asexual parasitaemia (/μl), GMR* [range] 26724
[2080–187200]
28992
[2097–189037]
26662
[2171–163840]
26134
[2073–186400]
22501
[1995–181970]
20352
[2455–162181]
19934
[2455–147911]
Temperature °C
median [range]
38.5
[37.5–40.2]
38.6
[37.5–40.5]
38.5
[37.5–40.6]
38.7
[37.5–40.6]
38.4
[37.5–40.5]
38.4
[37.5–41.0]
38.4
[37.5–40.5]
  1. *GMR = geometric mean